TrialJapanese journal of clinical oncology2013

Platinum-based chemotherapy plus cetuximab for the first-line treatment of Japanese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: results of a phase II trial.

Takayuki Yoshino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.